Ling Wang

US Patent:

8628672, Jan 14, 2014

Filed:

Jun 27, 2012

Appl. No.:

13/535091

Inventors:

Weimin Si - San Ramon CA, US
Ying Hong - Los Gatos CA, US
Zhigang Bai - Milpitas CA, US
Yunhe Huang - Pleasanton CA, US
Fenglin Liu - Milpitas CA, US
Hong Zhang - Fremont CA, US
Jikou Zhou - Pleasanton CA, US
Xiaoyu Yang - Union City CA, US
Yuan Yao - Fremont CA, US
Iulica Zana - Fremont CA, US
Feng Liu - San Ramon CA, US
Ling Wang - Hercules CA, US

Assignee:

Western Digital (Fremont), LLC - Fremont CA

International Classification:

B44C 1/22

US Classification:

216 22, 216 66, 216 67, 216 75

Abstract:

A method for fabricating a magnetic recording transducer having a magnetic writer pole with a short effective throat height is provided. In an embodiment, a writer structure comprising a magnetic writer pole having a trailing bevel and a nonmagnetic stack on the top surface of the writer pole is provided. A dielectric write gap layer comprising alumina is deposited over the trailing bevel section and the nonmagnetic stack; and at least one etch stop layer is deposited over the dielectric write gap layer. A layer of nonmagnetic fill material is deposited over the etch stop layer and to form a nonmagnetic bevel by performing a dry etch process. The etch stop layer(s) are removed from the short throat section; and a trailing shield is deposited over the short throat section, nonmagnetic bevel, and nonmagnetic stack top surface.

US Patent:

59255293, Jul 20, 1999

Filed:

Jun 7, 1995

Appl. No.:

8/483506

Inventors:

Shaun R. Coughlin - Tiburon CA
Ji Chen - San Francisco CA
Harold Bernstein - San Francisco CA
Maki Ishii - Kyoto, JP
Ling Wang - San Francisco CA
Mian Chen - San Francisco CA

Assignee:

The Regents of the University of California - Oakland CA

International Classification:

G01N 3353
G01N 33543

US Classification:

435 72

Abstract:

This invention relates to peptide ligand discovery and is particularly directed to a method for the discovery of agonists for membrane bound receptors. The inventive detection system involves the use of a "tethered" ligand for probing receptor binding. The general detection system includes a membrane, a membrane bound receptor, and a chimeric ligand presenting molecule. This chimeric protein forms the tethered ligand and in turn includes a membrane domain, a linker domain, a ligand domain, and a cleavable terminal domain. The "ligands" of the system are exposed by the addition of a specific peptidase that cleaves at the designated sequence. The sequence of the ligand that produces signal as a result of the interaction between the agonist and receptor can be then be isolated using sib selection.

US Patent:

20220275465, Sep 1, 2022

Filed:

Jan 28, 2022

Appl. No.:

17/649212

Inventors:

- Pleasanton CA, US
Jeffery Fong - Lafayette CA, US
Aaron T. Hamilton - Mountain House CA, US
Marintha Heil - Danville CA, US
Igor Kozlov - Danville CA, US
Ed Gustavo Marins - Brentwood CA, US
Elizabeth Marie Scott - San Ramon CA, US
Ling Wang - Dublin CA, US

International Classification:

C12Q 1/70
C12Q 1/686
C12Q 1/6848
C12Q 1/6888
C12Q 1/6816

Abstract:

Methods for the rapid detection of the presence or absence of Hepatitis B Virus (HBV) in a biological or non-biological sample are described. The methods can include performing an amplifying step, a hybridizing step, and a detecting step. Furthermore, primers, competitive blocking oligonucleotides, and probes targeting HBV (in particular HBV RNA, in particular, HBV RNA transcribed from cccDNA, such as pgRNA) and kits are provided that are designed for the detection of HBV (in particular HBV RNA, in particular, HBV RNA transcribed from cccDNA, such as pgRNA).

US Patent:

20220251670, Aug 11, 2022

Filed:

Jul 24, 2020

Appl. No.:

17/597725

Inventors:

- Pleasanton CA, US
Marintha Heil - Danville CA, US
Debra Liggett - Pleasanton CA, US
Jingtao Sun - San Ramon CA, US
Ling Wang - Dublin CA, US
Xiaoning Wu - Fremont CA, US

International Classification:

C12Q 1/70
C12Q 1/6813
C12Q 1/6844

Abstract:

Methods for the rapid detection of the presence or absence of Epstein Barr Virus (EBV) in a biological or non-biological sample are described. The methods can include performing an amplifying step, a hybridizing step, and a detecting step. Furthermore, primers and probes targeting EBV, and kits are provided that are designed for the detection of target regions of EBV. Also described are kits, reaction mixtures, and oligonucleotides (e.g., primer and probe) for the amplification and detection of EBV. Also described are primers and probes that detect different regions of EBV, and can be employed in a dual target assay for simultaneously detecting two different and non-overlapping target regions of EBV.